Literature DB >> 8554529

Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

E Elass-Rochard1, A Roseanu, D Legrand, M Trif, V Salmon, C Motas, J Montreuil, G Spik.   

Abstract

The ability of lactoferrin (Lf), an iron-binding glycoprotein that is also called lactotransferrin, to bind lipopolysaccharide (LPS) may be relevant to some of its biological properties. A knowledge of the LPS-binding site on Lf may help to explain the mechanism of its involvement in host defence. Our report reveals the presence of two Escherichia coli 055B5 LPS-binding sites on human Lf (hLf): a high-affinity binding site (Kd 3.6 +/- 1 nM) and a low-affinity binding site (Kd 390 +/- 20 nM). Bovine Lf (bLf), which shares about 70% amino acid sequence identity with hLf, exhibits the same behaviour towards LPS. Like hLf, bLf also contains a low- and a high-affinity LPS-binding site. The Kd value (4.5 +/- 2 nM) corresponding to the high-affinity binding site is similar to that obtained for hLf. Different LPS-binding sites for human serum transferrin have been suggested, as this protein, which is known to bind bacterial endotoxin, produced only 12% inhibition of hLf-LPS interaction. Binding and competitive binding experiments performed with the N-tryptic fragment (residues 4-283), the C-tryptic fragment (residues 284-692) and the N2-glycopeptide (residues 91-255) isolated from hLf have demonstrated that the high-affinity binding site is located in the N-terminal domain I of hLf, and the low-affinity binding site is present in the C-terminal lobe. The inhibition of hLf-LPS interaction by a synthetic octadecapeptide corresponding to residues 20-37 of hLf and lactoferricin B (residues 17-41), a proteolytic fragment from bLf, revealed the importance of the 28-34 loop region of hLf and the homologous region of bLf for LPS binding. Direct evidence that this amino acid sequence is involved in the high-affinity binding to LPS was demonstrated by assays carried out with EGS-loop hLf, a recombinant hLf mutated at residues 28-34.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554529      PMCID: PMC1136191          DOI: 10.1042/bj3120839

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  A bactericidal effect for human lactoferrin.

Authors:  R R Arnold; M F Cole; J R McGhee
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

2.  Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin.

Authors:  J Mazurier; G Spik
Journal:  Biochim Biophys Acta       Date:  1980-05-07

3.  Characterization and localization of an iron-binding 18-kDa glycopeptide isolated from the N-terminal half of human lactotransferrin.

Authors:  D Legrand; J Mazurier; M H Metz-Boutigue; J Jolles; P Jolles; J Montreuil; G Spik
Journal:  Biochim Biophys Acta       Date:  1984-05-31

Review 4.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  Lactoferricin, a new antimicrobial peptide.

Authors:  E M Jones; A Smart; G Bloomberg; L Burgess; M R Millar
Journal:  J Appl Bacteriol       Date:  1994-08

6.  Primary structure of the glycans from human lactotransferrin.

Authors:  G Spik; G Strecker; B Fournet; S Bouquelet; J Montreuil; L Dorland; H van Halbeek; J F Vliegenthart
Journal:  Eur J Biochem       Date:  1982-01

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 8.  [The role of lactotransferrin in the molecular mechanisms of antibacterial defense].

Authors:  G Spik; J Montreuil
Journal:  Bull Eur Physiopathol Respir       Date:  1983 Mar-Apr

9.  Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins.

Authors:  M H Metz-Boutigue; J Jollès; J Mazurier; F Schoentgen; D Legrand; G Spik; J Montreuil; P Jollès
Journal:  Eur J Biochem       Date:  1984-12-17

10.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Hepatitis C virus envelope proteins bind lactoferrin.

Authors:  M Yi; S Kaneko; D Y Yu; S Murakami
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

4.  Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice.

Authors:  M L Kruzel; Y Harari; C Y Chen; G A Castro
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

5.  Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.

Authors:  Jimmy F P Berbée; Claudia P Coomans; Marit Westerterp; Johannes A Romijn; Louis M Havekes; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

6.  Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity.

Authors:  Mojtaba Bagheri; Sandro Keller; Margitta Dathe
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

7.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

8.  Lactoferrin conjugated with 40-kDa branched poly(ethylene glycol) has an improved circulating half-life.

Authors:  Yasuhiro Nojima; Yosuke Suzuki; Kazuhiro Yoshida; Fumiko Abe; Tuneo Shiga; Takashi Takeuchi; Akihiko Sugiyama; Hirohiko Shimizu; Atsushi Sato
Journal:  Pharm Res       Date:  2009-06-25       Impact factor: 4.200

9.  The survival of ingested lactoferrin in the gastrointestinal tract of adult mice.

Authors:  H Kuwata; T T Yip; K Yamauchi; S Teraguchi; H Hayasawa; M Tomita; T W Hutchens
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

10.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.